Sign in
4

Changes in Ownership

Stoke Therapeutics, Inc. Filed Acc 0001966716-25-000006

GENERAL COUNSEL & CORP SEC sold 4,576 shares at an average $30.22 ($138,268)

  • GENERAL COUNSEL & CORP SEC acquired 12,357 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Allan Jonathan GENERAL COUNSEL & CORP SEC 2025-12-01 Option exercise +12,357 24,188 D: show line 1 in the form
Allan Jonathan GENERAL COUNSEL & CORP SEC 2025-12-02 Sale −1,416 $29.56 $41,860 22,772 D: show line 2 in the form
Allan Jonathan GENERAL COUNSEL & CORP SEC 2025-12-02 Sale −868 $30.14 $26,163 21,904 D: show line 3 in the form
Allan Jonathan GENERAL COUNSEL & CORP SEC 2025-12-03 Sale −898 $30.34 $27,244 21,006 D: show line 4 in the form
Allan Jonathan GENERAL COUNSEL & CORP SEC 2025-12-03 Sale −1,394 $30.85 $43,002 19,612 D: show line 5 in the form
Open-market sales · 4,576 sh · avg $30.22 · $138,268

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Allan Jonathan GENERAL COUNSEL & CORP SEC 2025-12-01 Option exercise · Restricted Stock Units −12,357 0 D: show line 6 in the form
Loading xslF345X05/form4-12042025_011223.xml…